Senate’s drug price hearing: 6 takeaways
(By Alia Paavola for Becker’s Hospital Review) Seven pharmaceutical executives, representing $140 billion in U.S. revenue, testified before the Senate Finance Committee
Read More(By Alia Paavola for Becker’s Hospital Review) Seven pharmaceutical executives, representing $140 billion in U.S. revenue, testified before the Senate Finance Committee
Read More(By Judith Graham for Kaiser Health News) Dr. Susan Wong sat down with an 84-year-old patient in the hospital, where
Read More(By Shefali Luthra for Kaiser Health News) Members of the House on Wednesday offered their version of a “Medicare-for-all” bill
Read MoreIf you are getting close to celebrating your 65th birthday, it’s time to review the rules for signing up for
Read More(By Elsa Pearson and Austin Frakt for STAT) When Medicare was signed into law in 1965, it did not include
Read More(By Morgan Haefner for Becker’s Hospital Review) The Department of Justice formally requested a judge sign off on its settlement
Read More(By Emmarie Huetteman and Jay Hancock for Kaiser Health News) Senators got their first opportunity Tuesday to prod drugmakers about
Read MoreThe new Medicare Advantage Open Enrollment Period goes from January 1st until March 31st. Many beneficiaries have many questions about
Read More(By Alia Paavola for Becker’s Hospital Review) Seven pharma executives will testify Feb. 26 before a U.S. Senate Finance Committee
Read More(By Karen Pollitz, Cynthia Cox and Rachel Fehr for Henry J. Kaiser Family Foundation) In this report, we analyze transparency
Read More